Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients
Chronic obstructive pulmonary disease (COPD) is a significant public health issue characterized by gradually worsening airflow limitation. It is a leading cause of mortality and morbidity worldwide, yet research on COPD patients who have never smoked is limited. This study aims to document the demog...
Gespeichert in:
| Veröffentlicht in: | International journal of chronic obstructive pulmonary disease 2024-01, Vol.19, p.2671-2688 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2688 |
|---|---|
| container_issue | |
| container_start_page | 2671 |
| container_title | International journal of chronic obstructive pulmonary disease |
| container_volume | 19 |
| creator | Fekete, Monika Horvath, Alpar Santa, Balazs Abonyi-Toth, Zsolt Tomisa, Gabor Szollosi, Gergo Jozsef Lehoczki, Andrea Fazekas-Pongor, Vince Varga, Janos Tamas |
| description | Chronic obstructive pulmonary disease (COPD) is a significant public health issue characterized by gradually worsening airflow limitation. It is a leading cause of mortality and morbidity worldwide, yet research on COPD patients who have never smoked is limited. This study aims to document the demographic, symptomatic, and therapeutic characteristics of COPD patients receiving outpatient pulmonary care in Hungary, focusing on smoking history, and evaluate their distribution according to the GOLD A/B/E classification.
The study recorded demographic data, symptom severity, occurrence of severe and moderate exacerbations, treatment, comorbidities, quality of life, and COVID-19 vaccination status among COPD patients from November 2021 to January 2023. A total of 6974 patients were categorized into current smokers, former smokers, and never smokers.
Patients had an average age of 67.2±8.9 years, with 48.2% male and 51.8% female. Of participants, 86.1% had a smoking history, while 13.9% had never smoked. COPD patients who had never smoked showed significantly better quality of life (CAT: 15.2±7.6 vs 15.8±6.9; p=0.006), oxygen saturation (SpO
%: 96.7±2.3 vs 95.8±2.4; p |
| doi_str_mv | 10.2147/COPD.S484664 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3146856407</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3146856407</sourcerecordid><originalsourceid>FETCH-LOGICAL-c206t-1bcb79f0df0b21b457de343ee50b391546beefa034b9b927c20e9e163adbbafb3</originalsourceid><addsrcrecordid>eNpdkDtPwzAUhS0EoqWwMaNILAyk2LFjJ2xVyksqtFJhjuzkpk3Jo9hJpf57HFoqxHSPrr5zhg-hS4KHHmHiLprOxsM5Cxjn7Aj1CRGB62HsH__JPXRmzMoGLgQ5RT0a2hBQr4_SUSWLrcmNU2dON3XvjHPT5NWizc3SHidaSi2TBnT3Towjq9R5lZVcQAlV09XmZf3ZkRvjvMEG9OExk01uGXOOTjJZGLjY3wH6eHx4j57dyfTpJRpN3MTDvHGJSpQIM5xmWHlEMV-kQBkF8LGiIfEZVwCZxJSpUIWesC0IgXAqU6VkpugA3ex217r-asE0cZmbBIpCVlC3JqaE8cDnDAuLXv9DV3WrrYsfyhde4DNmqdsdlejaGA1ZvNZ5KfU2Jjju7Medsnhv3-JX-9FWlZAe4F_d9BuB34AU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3145728544</pqid></control><display><type>article</type><title>Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients</title><source>Taylor & Francis Open Access</source><source>MEDLINE</source><source>DOVE Medical Press Journals</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Fekete, Monika ; Horvath, Alpar ; Santa, Balazs ; Abonyi-Toth, Zsolt ; Tomisa, Gabor ; Szollosi, Gergo Jozsef ; Lehoczki, Andrea ; Fazekas-Pongor, Vince ; Varga, Janos Tamas</creator><creatorcontrib>Fekete, Monika ; Horvath, Alpar ; Santa, Balazs ; Abonyi-Toth, Zsolt ; Tomisa, Gabor ; Szollosi, Gergo Jozsef ; Lehoczki, Andrea ; Fazekas-Pongor, Vince ; Varga, Janos Tamas</creatorcontrib><description>Chronic obstructive pulmonary disease (COPD) is a significant public health issue characterized by gradually worsening airflow limitation. It is a leading cause of mortality and morbidity worldwide, yet research on COPD patients who have never smoked is limited. This study aims to document the demographic, symptomatic, and therapeutic characteristics of COPD patients receiving outpatient pulmonary care in Hungary, focusing on smoking history, and evaluate their distribution according to the GOLD A/B/E classification.
The study recorded demographic data, symptom severity, occurrence of severe and moderate exacerbations, treatment, comorbidities, quality of life, and COVID-19 vaccination status among COPD patients from November 2021 to January 2023. A total of 6974 patients were categorized into current smokers, former smokers, and never smokers.
Patients had an average age of 67.2±8.9 years, with 48.2% male and 51.8% female. Of participants, 86.1% had a smoking history, while 13.9% had never smoked. COPD patients who had never smoked showed significantly better quality of life (CAT: 15.2±7.6 vs 15.8±6.9; p=0.006), oxygen saturation (SpO
%: 96.7±2.3 vs 95.8±2.4; p<0.001), higher body mass index (BMI: 29.4±5.9 vs 27.1±6.3; p<0.001), and better lung function (FEV
ref%: 67.9±20.7 vs 58.9±18.1; p<0.001) compared to smokers. However, non-smoking COPD patients had a higher frequency of comorbidities (3.5±2.2 vs 2.9±2.1; p<0.05). These differences may arise from complex genetic and environmental interactions.
COPD patients who have never smoked exhibited better quality of life, nutritional status, and lung function compared to smokers, indicating the need for tailored treatment approaches. Further long-term studies are essential to validate these differences in quality of life and lung function between smoking and non-smoking COPD patients.</description><identifier>ISSN: 1178-2005</identifier><identifier>ISSN: 1176-9106</identifier><identifier>EISSN: 1178-2005</identifier><identifier>DOI: 10.2147/COPD.S484664</identifier><identifier>PMID: 39677832</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Ltd</publisher><subject>Aged ; Air pollution ; Chronic obstructive pulmonary disease ; Comorbidity ; COVID-19 - epidemiology ; COVID-19 vaccines ; Ethics ; Ex-Smokers ; Female ; Humans ; Hungary - epidemiology ; Immunization ; Indoor air quality ; Infections ; Lung - physiopathology ; Lung diseases ; Male ; Middle Aged ; Non-Smokers ; Outdoor air quality ; Patients ; Pulmonary Disease, Chronic Obstructive - diagnosis ; Pulmonary Disease, Chronic Obstructive - epidemiology ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Pulmonary Disease, Chronic Obstructive - therapy ; Quality of Life ; Risk Factors ; Severe acute respiratory syndrome coronavirus 2 ; Severity of Illness Index ; Smokers ; Smoking - adverse effects ; Smoking - epidemiology ; Smoking Cessation</subject><ispartof>International journal of chronic obstructive pulmonary disease, 2024-01, Vol.19, p.2671-2688</ispartof><rights>2024 Fekete et al.</rights><rights>2024. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c206t-1bcb79f0df0b21b457de343ee50b391546beefa034b9b927c20e9e163adbbafb3</cites><orcidid>0000-0001-8632-2120 ; 0000-0002-5585-3313 ; 0000-0002-4285-7518 ; 0000-0001-7889-636X ; 0000-0002-4126-0058 ; 0000-0002-8552-1336 ; 0000-0003-3620-1691 ; 0009-0003-2547-7972 ; 0000-0002-6405-4003 ; 0000-0003-0183-0180 ; 0009-0000-6280-3130</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,3848,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39677832$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fekete, Monika</creatorcontrib><creatorcontrib>Horvath, Alpar</creatorcontrib><creatorcontrib>Santa, Balazs</creatorcontrib><creatorcontrib>Abonyi-Toth, Zsolt</creatorcontrib><creatorcontrib>Tomisa, Gabor</creatorcontrib><creatorcontrib>Szollosi, Gergo Jozsef</creatorcontrib><creatorcontrib>Lehoczki, Andrea</creatorcontrib><creatorcontrib>Fazekas-Pongor, Vince</creatorcontrib><creatorcontrib>Varga, Janos Tamas</creatorcontrib><title>Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients</title><title>International journal of chronic obstructive pulmonary disease</title><addtitle>Int J Chron Obstruct Pulmon Dis</addtitle><description>Chronic obstructive pulmonary disease (COPD) is a significant public health issue characterized by gradually worsening airflow limitation. It is a leading cause of mortality and morbidity worldwide, yet research on COPD patients who have never smoked is limited. This study aims to document the demographic, symptomatic, and therapeutic characteristics of COPD patients receiving outpatient pulmonary care in Hungary, focusing on smoking history, and evaluate their distribution according to the GOLD A/B/E classification.
The study recorded demographic data, symptom severity, occurrence of severe and moderate exacerbations, treatment, comorbidities, quality of life, and COVID-19 vaccination status among COPD patients from November 2021 to January 2023. A total of 6974 patients were categorized into current smokers, former smokers, and never smokers.
Patients had an average age of 67.2±8.9 years, with 48.2% male and 51.8% female. Of participants, 86.1% had a smoking history, while 13.9% had never smoked. COPD patients who had never smoked showed significantly better quality of life (CAT: 15.2±7.6 vs 15.8±6.9; p=0.006), oxygen saturation (SpO
%: 96.7±2.3 vs 95.8±2.4; p<0.001), higher body mass index (BMI: 29.4±5.9 vs 27.1±6.3; p<0.001), and better lung function (FEV
ref%: 67.9±20.7 vs 58.9±18.1; p<0.001) compared to smokers. However, non-smoking COPD patients had a higher frequency of comorbidities (3.5±2.2 vs 2.9±2.1; p<0.05). These differences may arise from complex genetic and environmental interactions.
COPD patients who have never smoked exhibited better quality of life, nutritional status, and lung function compared to smokers, indicating the need for tailored treatment approaches. Further long-term studies are essential to validate these differences in quality of life and lung function between smoking and non-smoking COPD patients.</description><subject>Aged</subject><subject>Air pollution</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Comorbidity</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 vaccines</subject><subject>Ethics</subject><subject>Ex-Smokers</subject><subject>Female</subject><subject>Humans</subject><subject>Hungary - epidemiology</subject><subject>Immunization</subject><subject>Indoor air quality</subject><subject>Infections</subject><subject>Lung - physiopathology</subject><subject>Lung diseases</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Non-Smokers</subject><subject>Outdoor air quality</subject><subject>Patients</subject><subject>Pulmonary Disease, Chronic Obstructive - diagnosis</subject><subject>Pulmonary Disease, Chronic Obstructive - epidemiology</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Pulmonary Disease, Chronic Obstructive - therapy</subject><subject>Quality of Life</subject><subject>Risk Factors</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Severity of Illness Index</subject><subject>Smokers</subject><subject>Smoking - adverse effects</subject><subject>Smoking - epidemiology</subject><subject>Smoking Cessation</subject><issn>1178-2005</issn><issn>1176-9106</issn><issn>1178-2005</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkDtPwzAUhS0EoqWwMaNILAyk2LFjJ2xVyksqtFJhjuzkpk3Jo9hJpf57HFoqxHSPrr5zhg-hS4KHHmHiLprOxsM5Cxjn7Aj1CRGB62HsH__JPXRmzMoGLgQ5RT0a2hBQr4_SUSWLrcmNU2dON3XvjHPT5NWizc3SHidaSi2TBnT3Towjq9R5lZVcQAlV09XmZf3ZkRvjvMEG9OExk01uGXOOTjJZGLjY3wH6eHx4j57dyfTpJRpN3MTDvHGJSpQIM5xmWHlEMV-kQBkF8LGiIfEZVwCZxJSpUIWesC0IgXAqU6VkpugA3ex217r-asE0cZmbBIpCVlC3JqaE8cDnDAuLXv9DV3WrrYsfyhde4DNmqdsdlejaGA1ZvNZ5KfU2Jjju7Medsnhv3-JX-9FWlZAe4F_d9BuB34AU</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Fekete, Monika</creator><creator>Horvath, Alpar</creator><creator>Santa, Balazs</creator><creator>Abonyi-Toth, Zsolt</creator><creator>Tomisa, Gabor</creator><creator>Szollosi, Gergo Jozsef</creator><creator>Lehoczki, Andrea</creator><creator>Fazekas-Pongor, Vince</creator><creator>Varga, Janos Tamas</creator><general>Dove Medical Press Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8632-2120</orcidid><orcidid>https://orcid.org/0000-0002-5585-3313</orcidid><orcidid>https://orcid.org/0000-0002-4285-7518</orcidid><orcidid>https://orcid.org/0000-0001-7889-636X</orcidid><orcidid>https://orcid.org/0000-0002-4126-0058</orcidid><orcidid>https://orcid.org/0000-0002-8552-1336</orcidid><orcidid>https://orcid.org/0000-0003-3620-1691</orcidid><orcidid>https://orcid.org/0009-0003-2547-7972</orcidid><orcidid>https://orcid.org/0000-0002-6405-4003</orcidid><orcidid>https://orcid.org/0000-0003-0183-0180</orcidid><orcidid>https://orcid.org/0009-0000-6280-3130</orcidid></search><sort><creationdate>20240101</creationdate><title>Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients</title><author>Fekete, Monika ; Horvath, Alpar ; Santa, Balazs ; Abonyi-Toth, Zsolt ; Tomisa, Gabor ; Szollosi, Gergo Jozsef ; Lehoczki, Andrea ; Fazekas-Pongor, Vince ; Varga, Janos Tamas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c206t-1bcb79f0df0b21b457de343ee50b391546beefa034b9b927c20e9e163adbbafb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Air pollution</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Comorbidity</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 vaccines</topic><topic>Ethics</topic><topic>Ex-Smokers</topic><topic>Female</topic><topic>Humans</topic><topic>Hungary - epidemiology</topic><topic>Immunization</topic><topic>Indoor air quality</topic><topic>Infections</topic><topic>Lung - physiopathology</topic><topic>Lung diseases</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Non-Smokers</topic><topic>Outdoor air quality</topic><topic>Patients</topic><topic>Pulmonary Disease, Chronic Obstructive - diagnosis</topic><topic>Pulmonary Disease, Chronic Obstructive - epidemiology</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Pulmonary Disease, Chronic Obstructive - therapy</topic><topic>Quality of Life</topic><topic>Risk Factors</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Severity of Illness Index</topic><topic>Smokers</topic><topic>Smoking - adverse effects</topic><topic>Smoking - epidemiology</topic><topic>Smoking Cessation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fekete, Monika</creatorcontrib><creatorcontrib>Horvath, Alpar</creatorcontrib><creatorcontrib>Santa, Balazs</creatorcontrib><creatorcontrib>Abonyi-Toth, Zsolt</creatorcontrib><creatorcontrib>Tomisa, Gabor</creatorcontrib><creatorcontrib>Szollosi, Gergo Jozsef</creatorcontrib><creatorcontrib>Lehoczki, Andrea</creatorcontrib><creatorcontrib>Fazekas-Pongor, Vince</creatorcontrib><creatorcontrib>Varga, Janos Tamas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of chronic obstructive pulmonary disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fekete, Monika</au><au>Horvath, Alpar</au><au>Santa, Balazs</au><au>Abonyi-Toth, Zsolt</au><au>Tomisa, Gabor</au><au>Szollosi, Gergo Jozsef</au><au>Lehoczki, Andrea</au><au>Fazekas-Pongor, Vince</au><au>Varga, Janos Tamas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients</atitle><jtitle>International journal of chronic obstructive pulmonary disease</jtitle><addtitle>Int J Chron Obstruct Pulmon Dis</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>19</volume><spage>2671</spage><epage>2688</epage><pages>2671-2688</pages><issn>1178-2005</issn><issn>1176-9106</issn><eissn>1178-2005</eissn><abstract>Chronic obstructive pulmonary disease (COPD) is a significant public health issue characterized by gradually worsening airflow limitation. It is a leading cause of mortality and morbidity worldwide, yet research on COPD patients who have never smoked is limited. This study aims to document the demographic, symptomatic, and therapeutic characteristics of COPD patients receiving outpatient pulmonary care in Hungary, focusing on smoking history, and evaluate their distribution according to the GOLD A/B/E classification.
The study recorded demographic data, symptom severity, occurrence of severe and moderate exacerbations, treatment, comorbidities, quality of life, and COVID-19 vaccination status among COPD patients from November 2021 to January 2023. A total of 6974 patients were categorized into current smokers, former smokers, and never smokers.
Patients had an average age of 67.2±8.9 years, with 48.2% male and 51.8% female. Of participants, 86.1% had a smoking history, while 13.9% had never smoked. COPD patients who had never smoked showed significantly better quality of life (CAT: 15.2±7.6 vs 15.8±6.9; p=0.006), oxygen saturation (SpO
%: 96.7±2.3 vs 95.8±2.4; p<0.001), higher body mass index (BMI: 29.4±5.9 vs 27.1±6.3; p<0.001), and better lung function (FEV
ref%: 67.9±20.7 vs 58.9±18.1; p<0.001) compared to smokers. However, non-smoking COPD patients had a higher frequency of comorbidities (3.5±2.2 vs 2.9±2.1; p<0.05). These differences may arise from complex genetic and environmental interactions.
COPD patients who have never smoked exhibited better quality of life, nutritional status, and lung function compared to smokers, indicating the need for tailored treatment approaches. Further long-term studies are essential to validate these differences in quality of life and lung function between smoking and non-smoking COPD patients.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Ltd</pub><pmid>39677832</pmid><doi>10.2147/COPD.S484664</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0001-8632-2120</orcidid><orcidid>https://orcid.org/0000-0002-5585-3313</orcidid><orcidid>https://orcid.org/0000-0002-4285-7518</orcidid><orcidid>https://orcid.org/0000-0001-7889-636X</orcidid><orcidid>https://orcid.org/0000-0002-4126-0058</orcidid><orcidid>https://orcid.org/0000-0002-8552-1336</orcidid><orcidid>https://orcid.org/0000-0003-3620-1691</orcidid><orcidid>https://orcid.org/0009-0003-2547-7972</orcidid><orcidid>https://orcid.org/0000-0002-6405-4003</orcidid><orcidid>https://orcid.org/0000-0003-0183-0180</orcidid><orcidid>https://orcid.org/0009-0000-6280-3130</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1178-2005 |
| ispartof | International journal of chronic obstructive pulmonary disease, 2024-01, Vol.19, p.2671-2688 |
| issn | 1178-2005 1176-9106 1178-2005 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3146856407 |
| source | Taylor & Francis Open Access; MEDLINE; DOVE Medical Press Journals; DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Aged Air pollution Chronic obstructive pulmonary disease Comorbidity COVID-19 - epidemiology COVID-19 vaccines Ethics Ex-Smokers Female Humans Hungary - epidemiology Immunization Indoor air quality Infections Lung - physiopathology Lung diseases Male Middle Aged Non-Smokers Outdoor air quality Patients Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary Disease, Chronic Obstructive - epidemiology Pulmonary Disease, Chronic Obstructive - physiopathology Pulmonary Disease, Chronic Obstructive - therapy Quality of Life Risk Factors Severe acute respiratory syndrome coronavirus 2 Severity of Illness Index Smokers Smoking - adverse effects Smoking - epidemiology Smoking Cessation |
| title | Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T07%3A30%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20COPD:%20Distinguishing%20Characteristics%20and%20Management%20of%20Smoking%20vs%20Never%20Smoking%20Patients&rft.jtitle=International%20journal%20of%20chronic%20obstructive%20pulmonary%20disease&rft.au=Fekete,%20Monika&rft.date=2024-01-01&rft.volume=19&rft.spage=2671&rft.epage=2688&rft.pages=2671-2688&rft.issn=1178-2005&rft.eissn=1178-2005&rft_id=info:doi/10.2147/COPD.S484664&rft_dat=%3Cproquest_cross%3E3146856407%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3145728544&rft_id=info:pmid/39677832&rfr_iscdi=true |